RALOXIFENE TEVA 60 mg, comprimé pelliculé — plaquette(s) thermoformée(s) aluminium PVC PVDC de 84 comprimé(s)
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400949335107 -
CIP7
4933510 -
CIS
67050747 -
Registration number
EU/1/10/627
What the source publishes
- Holder
- TEVA (PAYS-BAS)
- Active ingredients
- CHLORHYDRATE DE RALOXIFÈNE, RALOXIFÈNE BASE
- Form
- comprimé pelliculé
- Package
- plaquette(s) thermoformée(s) aluminium PVC PVDC de 84 comprimé(s)
- Routes
- orale
- Administrative status
- authorised
- Supply regime
- liste I
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 2010-04-29
- Prescription
- Prescription or restricted
Names this record is found by
- RALOXIFENE TEVA 60 mg, comprimé pelliculé — plaquette(s) thermoformée(s) aluminium PVC PVDC de 84 comprimé(s)
- RALOXIFENE TEVA 60 mg, comprimé pelliculé
- CHLORHYDRATE DE RALOXIFÈNE
- RALOXIFÈNE BASE
Complete source data
{
"cis": "67050747",
"cip7": "4933510",
"form": "comprimé pelliculé",
"name": "RALOXIFENE TEVA 60 mg, comprimé pelliculé — plaquette(s) thermoformée(s) aluminium PVC PVDC de 84 comprimé(s)",
"cip13": "3400949335107",
"holder": "TEVA (PAYS-BAS)",
"routes": [
"orale"
],
"holders": [
"TEVA (PAYS-BAS)"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": "33.63",
"authorisedOn": "2010-04-29",
"compositions": [
{
"name": "CHLORHYDRATE DE RALOXIFÈNE",
"nature": "SA",
"strength": "60 mg",
"linkageNumber": "1",
"substanceCode": "79270",
"dosageReference": "un comprimé",
"pharmaceuticalElement": "comprimé"
},
{
"name": "RALOXIFÈNE BASE",
"nature": "FT",
"strength": "56 mg",
"linkageNumber": "1",
"substanceCode": "93678",
"dosageReference": "un comprimé",
"pharmaceuticalElement": "comprimé"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "liste I",
"dispensingFee": "2.76",
"medicinePrice": "30.87",
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "RALOXIFENE TEVA 60 mg, comprimé pelliculé",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-01-08",
"CIS_CIP_bdpm": "2026-11-19",
"CIS_CPD_bdpm": "2026-01-08",
"CIS_COMPO_bdpm": "2026-01-08"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "oui",
"packageDescription": "plaquette(s) thermoformée(s) aluminium PVC PVDC de 84 comprimé(s)",
"patientEligibility": "not-assessed",
"reimbursementRates": [
"65%"
],
"marketingDeclaredOn": "2011-03-15",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"CHLORHYDRATE DE RALOXIFÈNE",
"RALOXIFÈNE BASE"
],
"authorisationProcedure": "Procédure centralisée",
"prescriptionConditions": [
"liste I"
],
"reimbursementIndications": "Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Prévention et traitement de l'ostéoporose postménopausique du rachis, pour réduire le risque de fractures vertébrales, chez les femmes âgées de moins de 70 ans, sans facteur de risque veineux et avec apport de calcium<br> ; JOURNAL OFFICIEL ; 17/05/01",
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": "EU/1/10/627",
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400949335107"